Imaging & brain
Imagerie et cerveau
News
Today's news is the story of tomorrow.
- [EVENEMENT] InScience 2023 - Radioconférence Les ultrasons pour traiter les troubles neuropsychiatriquesJune 8, 2023Radio conférence avec Ayache Bouakaz
- [EVENEMENT] InScience 2023 - Exposition Zoom sur les cellules du cerveauJune 1, 2023 - June 15, 2023Exposition illustrée de photos de l'INSERM en microscopie électronique ou à fluorescence
- [PUBLICATION] Glutamate levels of the right and left anterior cingulate cortex in autistics adultMay 31, 2023 - June 26, 2023Une publication collaborative entre l'équipe Psychiatrie Neurofonctionnelle et l'équipe Imagerie, biomarqueurs et Thérapie avec Frédéric Briend et Marie Gomot dans Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Some numbers...
Researchers & Academics
Students
Engineers and Technicians
Who are we?
The Imaging and Brain Unit (iBrain, Inserm Unit 1253) is a multidisciplinary unit integrating research in Psychiatry, studies in cellular/molecular neuroscience and investigations aimed at developing new technologies for diagnosis and treatment of psychiatric disorders (focusing on methodologies relying on radiopharmaceuticals and ultrasound). It gathers experts in acoustics, chemistry, genetics, philosophy, psychiatry, linguistics, medical imaging, mathematics, neuroscience, philosophy, physics and radiochemistry.
Its main objective is to develop personalized therapies for psychiatric disorders, in particular autism and treatment-resistant depression, based on specific biomarkers predicting the efficacy of a given treatment.
The specific objectives of the unit are:
- to improve the comprehension of psychiatric and neurologic disorders by refining diagnosis and treatment
- to develop new imaging technologies and methodologies for the exploration of brain pathologies
- to develop innovative therapies for the treatment of cerebral pathologies
Neuro‐functional Psychiatry
We are studying the neurophysiological mechanisms involved in two psychiatric diseases: Autism and Depression. In the Autism project, we analyze neurophysiological signals and identify bioclinical signatures of autism. In the Depression project, we are looking for specific markers predicting the response / nonresponse to antidepressants and we are developing new innovative therapies.
More
Neurogenomics and Neuronal Physiopathology
We seek to identify and study clinical, genetic, molecular, and pathophysiological markers in Intellectual Disabilities and Amyotrophic Lateral Sclerosis, specifically targeting glutamatergic neurons and their neuronal connections.
More
More
Imaging, Biomarkers and Therapy
We develop and validate imaging technologies (Ultrasound, PET, MRI) to understand the neurophysiological mechanisms of psychiatric diseases. We develop new therapeutic strategies based on the use of ultrasound (ultrasound neurostimulation, sonoporation).
More
More
Get in Touch
| UMR 1253 Imagerie & Cerveau Faculté de Médecine 10 Bd Tonnellé Bât. Thérèse Planiol 37032 Tours Cedex 1 Secrétariat de l'unité Tel : + 33 (0)2 47 36 63 51 Email : u1253@univ-tours.fr |